Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Gemma Medcalf

- PMLiVE

UK universities awarded over £58m by Cancer Research UK for clinician scientist training

The funding builds on the charity’s previous Clinical Academic Training Programme Award investment in 2019

- PMLiVE

Two UK clinical trials launched to identify blood tests for dementia diagnosis

The neurodegenerative condition affects more than 944,000 people in the UK

- PMLiVE

World Health Organization launches AI-powered digital health assistant for public health

SARAH has been launched in alignment with World Health Day’s theme, ‘My Health, My Right’

- PMLiVE

minds + assembly appoints Nick Colucci to board of directors

Colucci previously served as chief executive officer and chairman of Publicis Health

- PMLiVE

The whys and whats of professional associations

Highlighting the importance of joining your sector’s professional association

- PMLiVE

Streamlining Asynchronous Feedback: Scale Consistency – Impetus InSite Tips #2

Uncover the second crucial tip for optimizing your asynchronous virtual meetings. Learn the importance of scale consistency in survey-style questions on the Impetus InSite Platform to ensure clear and reliable...

Impetus Digital

- PMLiVE

Bristol Myers Squibb’s Reblozyl receives EC approval in myelodysplastic syndromes

The treatment is already approved in the EU to treat anaemia in adults with beta-thalassaemia

- PMLiVE

FDA approves Basilea’s intravenous antibiotic Zevtera for three indications

The regulator’s decision provides an additional treatment option for a number of serious bacterial infections

- PMLiVE

NHS rolls out artificial pancreas for adults and children with type 1 diabetes in England

Type 1 diabetes accounts for approximately 10% of all diabetes cases in the UK

- PMLiVE

NICE backs post-stroke genetic testing to identify most suitable treatment options

An estimated 32% of people in the UK have at least one of the highlighted CYP2C19 gene variants

- PMLiVE

Ten participating drugmakers invited for further US Medicare drug price negotiations

ASPE revealed that the IRA is expected to save around 857,000 US women $1,000 or more in 2025

- PMLiVE

The threat of AMR – when the drugs no longer work…

In the face of the increasing threat from AMR, the recent Bioinfect 2024 conference offers five reasons to be hopeful

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links